Heart Tronics Inc (HRTT)

[TechKim]

Heart Response Under Extreme Conditions - Signalife Technology Featured on CBC
Friday July 27, 9:24 am ET


GREENVILLE, S.C., July 27 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN - News) has announced that a video footage of its technology use during Champ Car Grand Prix of Edmonton is now available online. The report was made by Terry Reith of Canadian Broadcasting Company (CBC) during last weekend's race in Edmonton. To view the video, please click on Signalife link below:



http://www.signalife.com/Pages/newsPDF/2007/pr07252007.html

Signalife patented signal processing technology enables recording of high- fidelity ECG data in harsh environment. The collaboration between the Signalife and Champ Car started in the Fall of 2005, as a joint three-way collaborative effort, when Dr. Jennifer Cummings of Cleveland Clinic introduced Signalife R&D team to the Champ Car World Series (CCWS) Medical Director Dr. Chris Pinderski. Open cockpit race cars, such as in CCWS, house a large number of electronic instrumentation and communication devices and also subject drivers to constant vibrations of the road course and high G-force impacts. This harsh environment represents a great challenge for ECG monitoring. In addition, due to discomfort, drivers could not tolerate the use of traditional wet-gel electrodes for recording ECG data. As a result, dry electrodes and a custom designed garment have been developed. The use of dry electrodes on unprepared skin represented enormous challenge for quality ECG recordings. During a race, driver is fitted with a special fire-protective shirt with embedded dry electrodes and ECG signal is recorded by the on-board recorder while heart rate information is transmitted over vehicle telemetry channel. After two years of development, Signalife system performed flawlessly during two races in Canada.

Dr. Budimir S. Drakulic, Signalife Chief Technology Officer stated: "The first phase of our joint effort with Champ Car World Series and Jennifer Cummings, MD of Cleveland Clinic is successfully accomplished. We can collect and transmit in real time ECG data during a race. Physicians from Champ Car and Cleveland Clinic will be able to analyze and use these data to enhance performance and safety of drivers."

About Signalife

Signalife, Inc. is a life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting.

Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://www.Signalife.com. Clear Data. Trusted Results.

Caution Regarding Forward-Looking Statements

Statements in this release that are not strictly historical are "forward- looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the unavailability of financing to complete management's plans and objectives, including the development of heart monitoring and other biomedical incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities and Exchange Commission.




--------------------------------------------------------------------------------
Source: Signalife, Inc.